Informed Consent and Genetic Testing

Informed consent for genetic testing is the process by which a patient, after appropriate counseling, voluntarily authorizes a test having understood its purpose, possible results, and broader implications. Because genetic results can carry probabilistic, lifelong, and familial consequences—including incidental and secondary findings—consent for genetic and genomic testing raises distinctive informational and ethical demands compared with routine clinical tests.

Definition

Informed consent for genetic testing is the voluntary, competent authorization a patient gives—after disclosure of the test's purpose, possible results, limitations, and personal and familial implications—to undergo a genetic or genomic test.

Scope

This topic covers the elements and special features of consent for genetic and genomic testing: disclosure of test purpose and limitations, possible result categories including uncertain and incidental findings, implications for relatives, and the role of pretest counseling. It is a conceptual and ethical reference, not operational guidance or a consent template for a specific test.

Core questions

• What information must be disclosed before a genetic or genomic test?
• How should the possibility of uncertain, incidental, or secondary findings be handled in consent?
• How does the familial nature of genetic results affect what consent should cover?
• What is the relationship between pretest counseling and valid consent?

Key concepts

• Voluntariness and competence
• Disclosure of test purpose and limitations
• Variants of uncertain significance
• Incidental and secondary findings
• Implications for relatives
• Pretest counseling
• Right not to know

Mechanisms

Valid consent for genetic testing typically follows pretest counseling in which the purpose, possible outcomes, limitations, and personal and familial implications of the test are discussed so that the patient can make a voluntary, informed choice. For genome and exome sequencing, professional guidance highlights that consent should address the possibility of incidental or secondary findings and variants of uncertain significance, which distinguishes it from consent for narrowly targeted tests. Because results may inform relatives' risks, the consent conversation often also considers how information might later be shared within the family.

Clinical relevance

Consent for genetic testing illustrates how the ethical principle of autonomy is operationalized when results are probabilistic, durable, and shared across a family. This entry describes the components and rationale of that consent process for reference and education; it is not a consent form, protocol, or instruction for testing a particular individual.

Evidence & guidelines

Professional bodies have published points-to-consider statements on consent for genomic sequencing that emphasize disclosure of secondary findings and uncertain results; the systematic-review literature on family communication documents how testing decisions and their familial implications are handled. The ACMG points-to-consider statement is a frequently cited reference for sequencing consent.

History

As genetic testing expanded from single-gene tests to broad genomic sequencing, the scope of what consent must cover grew accordingly. Early consent practice focused on targeted tests with discrete results, but the advent of exome and genome sequencing forced explicit attention to incidental and secondary findings and to variants of uncertain significance, prompting professional points-to-consider statements that reshaped the consent conversation.

Debates

How should secondary and incidental findings be addressed in consent?

There is ongoing discussion about whether and how patients should choose to receive secondary findings, and how to convey the possibility of uncertain results without overwhelming the consent process.

Key figures

• Angus Clarke
• Clara Gaff
• Patricia McCarthy Veach

Seminal works

• acmg-2013
• gaff-2007

Frequently asked questions

How is consent for a genetic test different from consent for an ordinary blood test?

Genetic results can be probabilistic, lifelong, and relevant to relatives, and genomic tests may reveal incidental or uncertain findings, so consent typically follows counseling and addresses these broader implications.

What are secondary findings, and why do they matter for consent?

Secondary findings are medically relevant results unrelated to the original reason for testing that genomic sequencing may uncover; consent for sequencing should address whether and how such findings will be returned.